Monsanto First-Quarter Profit Up on South America Strength

Monsanto Co. reported higher earnings in the first quarter than the prior year on strong demand from its South American business.

Net income was $29 million in the first quarter, reversing a $253 million loss in the year-ago period. Total crop protection, or Agricultural Productivity, sales dropped to $802 million from $820 million in the prior-year quarter. Seeds and Genomics sales were stronger, climbing to $1.8 billion from $1.4 billion.

“We’ve been very pleased with the strong support — especially from shareowners and growers — for the agreement to combine with Bayer,” said Hugh Grant, chairman and chief executive officer. “We expect the combination with Bayer to amplify the rate of innovation faster than either company could achieve alone, which will be critical in helping to increase grower productivity to meet projected demand in the decades ahead.”

With the expected strong start in the first quarter and continued focus on return on innovation and financial discipline, the company remains confident in its fiscal year 2017 outlook. Despite the fact that the year-over-year change in currency rates was modestly favorable in the first quarter of fiscal year 2017, the company continues to assume that the change in rates will have a relatively neutral effect on a full year basis given the recent strengthening of the U.S. dollar against several currencies.

The fiscal year 2017 full-year as-reported EPS guidance is expected to be in the range of $3.97 to $4.45. These earnings are expected to translate into $2.4-to-$2.8 billion of operating cash flows and $1.4-to-$1.6 billion of free cash flows, after deducting an estimated $1.0-to-$1.2 billion of investing cash flows. These investing cash flows reflect the planned investment in the company’s dicamba manufacturing facility and assume the successful sale of the precision agriculture equipment business.

The company expects roughly $100 million of gross profit from strategic licensing deals towards the end of the fiscal year which is anticipated to be roughly split between Seeds and Genomics and Ag Productivity. Seeds and Genomics segment gross profit is expected to increase to mid-single digits as a percent year-over-year, with soybean gross profit alone expected to grow by more than 20 percent, driven by new trait penetration and an anticipated reduction in cost of goods sold. In corn, growth is expected to come from global genetic share gains and global germplasm price mix lift in local currency that is flat to up low-single-digits, in terms of percentages. The company expects global corn acres to be roughly flat, with declines in U.S. corn acreage offset by the early increases in South America.

The company adjusted Ag Productivity gross profit to the expected range of $850-to-$950 million, reflecting year-over-year price declines in glyphosate-based herbicides in the first half of the year, offset partially by the benefit of licensing opportunities and expected higher volumes. The adjustment in gross profit outlook is a result of the approximately $85 million benefit from the sale of the Latitude wheat fungicide business that was ultimately recorded in other expense, net for the segment, as opposed to gross profit as anticipated.

The company’s restructuring and cost savings initiatives remain on track, with the opportunity to deliver approximately $380 million in annual savings at the close of fiscal 2017 in operating expenses and cost of good sold, as compared to fiscal year 2015. However, setting aside pending Bayer transaction related costs and restructuring expenses, overall operating expenses in fiscal 2017 are expected to increase slightly with inflation and the costs associated with the return to growth of the business more than offsetting the savings. The expected tax rate for the year remains in the range of 25-to-28 percent.

For the second quarter of fiscal year 2017, the company expects as-reported and ongoing earnings per share that is approximately $0.20 to $0.50 better than the prior year. The company sees this first half earnings improvement as a reflection of the benefit from the sale of the Latitude business and the absence of a significant portion of the Argentine peso devaluation from the prior year. In the second half of the fiscal year, the company expects roughly 40 cents less in earnings per share benefit from strategic deals versus the prior year in addition to a more challenging currency environment than in the first quarter.

The company’s higher Seeds and Genomics sales in the first quarter included a 25-plus percent increase in planted corn acres in Argentina and more than a 10 percent increase in corn acres planted in Brazil accompanied by double-digit price increases in corn germplasm in local currency in both countries. In the U.S., demand for year-one hybrids remains strong and the early read on the order book supports the company’s intention to grow genetic share.

The company continues to build on the momentum of Intacta RR2 PRO soybeans in South America as it remains on track to reach a target of 45 to 55 million acres in fiscal year 2017. In the U.S., demand for Roundup Ready 2 Xtendsoybeans remains strong and the company is well-supplied for more than 15 million acres of the product. With the EPA approval for in-crop use of dicamba in-hand, the company has received nearly two-thirds of the necessary state approvals for both soybeans and cotton, and expects to have the rest before planting. The company said it has provided extensive, ongoing customer training and expects customers will have an outstanding experience with the Roundup Ready® Xtend crop system.

Topics: , , ,

Agrichemicals

Adjuvants

Before a New Weed-Control Era Begins, One Last Obstacle

Adjuvant companies anxious for tank-mixing approvals with D-traited technologies as application season closes in.

Agrichemicals

Mitsui Acquires 10% Stake in Belchim Crop Protection

The companies cited lengthy development cycles, increased regulatory demands and costs and market changes for intensifying their cooperation.

Adjuvants

Oxiteno Expands Business in the U.S., to Construct Plant

Oxiteno appointed Timothy Earl Madden as COO of Oxiteno USA.

Africa/Middle East

Syngenta Sales Boosted by Strength in Europe, Africa and Middle East

The company expects its pending merger with ChemChina to close in the second quarter of 2017.

Agrichemicals

Arysta, DuPont to Develop New Insecticides Based on Rynaxypyr

The long-term agreement between the two companies allows Arysta LifeScience to combine Rynaxypyr insect control in premixes with acetamiprid.

Agrichemicals

Just ‘Okay’ Isn’t Good Enough with Dicamba Cropping Systems

Thus far, crop protection product experts have a very simple message for custom applicators who plan to use the new dicamba herbicides in their operations for 2017 – follow the label, or else!

nufarm logo
Agrichemicals

Nufarm Launches New Seed Treatment Solutions

The new products include three new Spirato seed treatments, Sativa IMF Sembolite MAX, and Salient 372 FS.

Agrichemicals

FMC Ag Solutions Profit Rises in Fourth Quarter

Profit boosted by strong pricing in Latin America despite the strengthening of the U.S. dollar.

Agrichemicals

Stockton’s ‘Hybrid’ Conventional/Bio Fungicide Registered in Israel

REGEV, its first ever hybrid fungicide, obtained registration from the Ministry of Agriculture in Israel for the control of fungal plant diseases.

Agrichemicals

Arysta LifeScience Receives EPA Approval on Two In-Furrow Products

TEPERA brand fungicides will help corn, soybean plants get an early, healthy start.

Agrichemicals

Slower to Pull the Trigger on Fungicides, U.S. Growers Asking More Questions

"Growers will try to do some scouting and decision-making on whether they really need that product or not based on probability of return.” -Damon Smith, University of Wisconsin

Agrichemicals

India’s Registration Committee Adopts New Rules for Import and Manufacturing

The Registration Committee considered the governments “Make in India” agenda while deliberating issues and suggesting various changes to the rules

Agrichemicals

Opinion: Trump’s Trans-Pacific Partnership Decision a Head Scratcher

Editor’s Note: Matthew J. Grassi is Field Editor with CropLife® magazine a sister publication to AgriBusiness Global. Matthew can be reached

Agrichemicals

BASF Enters Indian Crop Protection Market for Rice

Range of new solutions to boost rice yields in India by managing diseases, weeds and pests.

Africa/Middle East

An Invitation to Be Rewarded for Environmental Excellence

Dear Crop Protection Professional, As an AgriBusiness Global™ reader, you’re no doubt aware we organize the Environmental Respect Awards each

Agrichemicals

Brazil Suspends 63 Fungicides Targeting Asian Soybean Rust

Resistance of the fungus to fungicides has spread widely in the country.

Africa/Middle East

Farmers Scrutinize Costs as Acreage for Major Crops Decreases

The total planting area of eight staple crops in the United States will decline almost annually through 2026, with acreage

Agrichemicals

Syngenta CEO Expects Merger Regulatory Approval Soon – Reuters

Syngenta Chief Executive Erik Fyrwald expects regulatory approval soon for ChemChina’s proposed $43 billion takeover of the Swiss pesticides and

Agrichemicals

Embrapa, Bayer to Map Mechanism of Soybean Disease Resistance to Fungicides

The Brazilian Agricultural Research Corporation (Embrapa) and Bayer have established a partnership to study the mechanisms that cause soybean pathogenic

Latest News

Adjuvants

Before a New Weed-Control Era Begins, One Last Obstacle

Adjuvant companies anxious for tank-mixing approvals with D-traited technologies as application season closes in.

Industry News

Acadian Plant Health Hires First Director of Product Life Cycle Management

Acadian Plant Health (APH) recently announced that Shane Hand had been hired to fill a newly-formed position within the organization.

Americas

Marrone Bio Innovations and Groundwork BioAg Test Bio-stacked Microbial Seed Treatments

The treatments tested in corn and soybeans contained a mycorrhizal inoculant from Groundwork, as well as a bioinsecticide, a bionematicide, and a biofungicide from Marrone.

Agrichemicals

Mitsui Acquires 10% Stake in Belchim Crop Protection

The companies cited lengthy development cycles, increased regulatory demands and costs and market changes for intensifying their cooperation.

Adjuvants

Oxiteno Expands Business in the U.S., to Construct Plant

Oxiteno appointed Timothy Earl Madden as COO of Oxiteno USA.